Literature DB >> 22492060

The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.

Rishi Puri1, Yu Kataoka, Kiyoko Uno, Stephen J Nicholls.   

Abstract

As the incidence of diabetes mellitus continues to rise, parallel increases in the rates of diabetic atherosclerotic vascular disease are projected to impart major health and socioeconomic challenges for authorities worldwide. Diabetes results in a proatherogenic phenotype, manifesting in an accelerated, diffuse, polyvascular fashion. In this review, we highlight the pathophysiological and morphological hallmarks of diabetic atherosclerosis.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22492060     DOI： 10.1007/s11892-012-0270-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  59 in total

1.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.

Authors:  H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro.

Authors:  R Assert; G Scherk; A Bumbure; V Pirags; H Schatz; A F Pfeiffer
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

3.  Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis.

Authors:  K-Raman Purushothaman; Meerarani Purushothaman; Paul Muntner; Patrick A Lento; William N O'Connor; Samin K Sharma; Valentin Fuster; Pedro R Moreno
Journal:  Vasc Med       Date:  2011-04       Impact factor: 3.239

4.  Noninvasive assessment of plaque characteristics with multislice computed tomography coronary angiography in symptomatic diabetic patients.

Authors:  Gabija Pundziute; Joanne D Schuijf; J Wouter Jukema; Eric Boersma; Arthur J H A Scholte; Lucia J M Kroft; Ernst E van der Wall; Jeroen J Bax
Journal:  Diabetes Care       Date:  2007-01-26       Impact factor: 19.112

Review 5.  Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus.

Authors:  Shailesh Nandish; Jamison Wyatt; Oscar Bailon; Mike Smith; Rene Oliveros; Robert Chilton
Journal:  Am J Cardiol       Date:  2011-08-02       Impact factor: 2.778

6.  Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin.

Authors:  F H de Man; A W Weverling-Rijnsburger; A van der Laarse; A H Smelt; J W Jukema; G J Blauw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

Review 7.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

8.  Prediction of coronary heart disease in middle-aged adults with diabetes.

Authors:  Aaron R Folsom; Lloyd E Chambless; Bruce B Duncan; Adam C Gilbert; James S Pankow
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

9.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.

Authors:  H H Ting; F K Timimi; K S Boles; S J Creager; P Ganz; M A Creager
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

10.  Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  H C McGill; C A McMahan; G T Malcom; M C Oalmann; J P Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311
View more
  4 in total

1.  Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients.

Authors:  Changlei Guo; Fudong Hu; Shaoli Zhang; Yakun Wang; Hengdao Liu
Journal:  Genet Mol Biol       Date:  2013-05-17       Impact factor: 1.771

2.  MicroRNA-146a decreases high glucose/thrombin-induced endothelial inflammation by inhibiting NAPDH oxidase 4 expression.

Authors:  Huang-Joe Wang; Yuan-Li Huang; Ya-Yun Shih; Hsing-Yu Wu; Ching-Tien Peng; Wan-Yu Lo
Journal:  Mediators Inflamm       Date:  2014-09-14       Impact factor: 4.711

Review 3.  Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches.

Authors:  Suvi E Heinonen; Guillem Genové; Eva Bengtsson; Thomas Hübschle; Lina Åkesson; Katrin Hiss; Agnes Benardeau; Seppo Ylä-Herttuala; Ann-Cathrine Jönsson-Rylander; Maria F Gomez
Journal:  J Diabetes Res       Date:  2015-02-15       Impact factor: 4.011

Review 4.  Immune mechanisms in atherosclerosis, especially in diabetes type 2.

Authors:  Johan Frostegård
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.